Trends in Epidemiology and Mortality of Patients With Hypertension in Germany: A Retrospective Study Using German Claims Data
Author(s)
Müller S1, Dornig S2, Wilke T3, Mevius A3
1GIPAM GmbH, Wismar, MV, Germany, 2AOK PLUS, Jena, Germany, 3Institut für Pharmakoökonomie und Arzneimittellogistik (IPAM), Wismar, MV, Germany
OBJECTIVES: Despite progress in the early detection and treatment of hypertension, it remains a common diagnosis in aging population in Western countries, associated with a substantial cardiovascular event risk. This research aimed to estimate the incidence/prevalence of hypertension in Germany and to describe trends in mortality in the last ten years.
METHODS: Utilizing claims data from AOK PLUS (German sickness fund with 3.5 million insured persons), hypertension cases were identified by outpatient and inpatient diagnoses (ICD-10-GM: I10). Cumulative incidence in 2012/2022 and point prevalence on January 1st of the following year were assessed and extrapolated (age-/gender-standardized) to the overall German population. Standardized mortality rates for 2012/2022 were evaluated in cross-sectional hypertension samples.
RESULTS: Age-/gender-standardized German hypertension incidence and prevalence in 2012/2022 were 2.4%/1.9% and 33.5%/33.5%, respectively. Based on a German population of 83.8 million persons, this translates into 1.64 million incident hypertension cases in the year 2022 and 28.1 million-prevalent patients on January 1, 2023. Yearly mortality in the extrapolated prevalent GER hypertension population were 2.0% in 2012 and 3.2% in 2022.
CONCLUSIONS: Hypertension incidence and prevalence is very high and estimates based on claims data are slightly higher than in other official statistics, probably due to a certain degree of overreporting in claims data, but mainly due to missed cases in official statistics. Even if mortality causes are not known, with practically one third of the GER population suffering from hypertension combined with an increasing mortality in this population the health care burden due to this disease is high.
Conference/Value in Health Info
Value in Health, Volume 27, Issue 12, S2 (December 2024)
Code
EPH167
Topic
Epidemiology & Public Health
Disease
Cardiovascular Disorders (including MI, Stroke, Circulatory), No Additional Disease & Conditions/Specialized Treatment Areas